CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-20 | HILL DAVID LOUIS Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | MORSE DANIEL E. Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | Olson Charles V Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | SAMPAT MAYANK D. Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | Chun Paul Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-12-22 | MCPARTLAND MARK A. (See Remarks) | Grant or award · Share Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-12-22 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-12-22 | BRISSON MARY CATHERINE Chief Operating Officer | Grant or award · Share Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-12-22 | OAKES FRANK R. President, CEO & Director | Option exercise | +4,000 | $2.86 | $11K | 197,965 |
| 2015-12-22 | OAKES FRANK R. President, CEO & Director | Gift | −9,000 | 188,965 | ||
| 2015-11-24 | OAKES FRANK R. President, CEO & Director | Option exercise | −150,000 | $2.50 | $375K | 193,965 |
| 2015-11-24 | OAKES FRANK R. President, CEO & Director | Option exercise · Call Option (Obligation to Sell) | −150,000 | 0 | ||
| 2015-06-10 | MORSE DANIEL E. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-06-10 | HILL DAVID LOUIS Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2014-12-18 | OAKES FRANK R. President, CEO & Director | Gift | −14,000 | 1,953,646 | ||
| 2014-12-18 | OAKES FRANK R. President, CEO & Director | Gift | −14,000 | 1,939,646 | ||
| 2014-11-12 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Stock Option (Right To Buy) | +90,000 | 90,000 | ||
| 2014-11-12 | BAXTER GREGORY T. Director | Grant or award · Stock Option (Right To Buy) | +12,500 | 12,500 |
Page 16 of 16 · 319 trades